Atherosclerosis
Volume 192, Issue 2 , Pages 275-282 , June 2007

Imaging of vulnerable atherosclerotic plaques with FDG-microPET: No FDG accumulation

  • Jacob Marsvin Laurberg

      Affiliations

    • Department of Cardiology and Institute of Clinical Medicine, Aarhus University Hospital (Skejby), Aarhus, Denmark
    • Corresponding Author InformationCorresponding author at: Department of Cardiology, Research Unit, Aarhus University Hospital (Skejby), Brendstrupgaardsvej, DK-8200 Aarhus N, Denmark. Tel.: +45 8949 6231; fax: +45 8949 6009.
    • ,
  • Aage Kristian Olsen

      Affiliations

    • The PET Centre, Aarhus University Hospital, Aarhus, Denmark
    • ,
  • Søren Baarsgaard Hansen

      Affiliations

    • The PET Centre, Aarhus University Hospital, Aarhus, Denmark
    • ,
  • Morten Bottcher

      Affiliations

    • Department of Cardiology and Institute of Clinical Medicine, Aarhus University Hospital (Skejby), Aarhus, Denmark
    • ,
  • Matthew Morrison

      Affiliations

    • GE Healthcare, The Grove Centre, Amersham, UK
    • ,
  • Sally-Ann Ricketts

      Affiliations

    • GE Healthcare, The Grove Centre, Amersham, UK
    • ,
  • Erling Falk

      Affiliations

    • Department of Cardiology and Institute of Clinical Medicine, Aarhus University Hospital (Skejby), Aarhus, Denmark

Received 25 January 2006 ,Revised 13 June 2006 ,Accepted 11 July 2006.

References 

  1. Ross R. Atherosclerosis—an inflammatory disease. N Engl J Med. 1999;340(2):115–126
  2. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation. 1995;92(3):657–671
  3. Gibbons RJ, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina—summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). Circulation. 2003;107(1):149–158
  4. Fayad ZA, Fuster V, Nikolaou K, Becker C. Computed tomography and magnetic resonance imaging for noninvasive coronary angiography and plaque imaging: current and potential future concepts. Circulation. 2002;106(15):2026–2034
  5. Davies JR, Rudd JH, Weissberg PL. Molecular and metabolic imaging of atherosclerosis. J Nucl Med. 2004;45(11):1898–1907
  6. Schelbert HR, Inubushi M, Ross RS. PET imaging in small animals. J Nucl Cardiol. 2003;10(5):513–520
  7. Gambhir SS, Czernin J, Schwimmer J, et al. A tabulated summary of the FDG PET literature. J Nucl Med. 2001 May;42(5 Suppl):1S–93S
  8. Kubota R, Yamada S, Kubota K, et al. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med. 1992;33(11):1972–1980
  9. Ishimori T, Saga T, Mamede M, et al. Increased (18)F-FDG uptake in a model of inflammation: concanavalin A-mediated lymphocyte activation. J Nucl Med. 2002;43(5):658–663
  10. Tatsumi M, Cohade C, Nakamoto Y, Wahl RL. Fluorodeoxyglucose uptake in the aortic wall at PET/CT: possible finding for active atherosclerosis. Radiology. 2003;229(3):831–837
  11. Yun M, Yeh D, Araujo LI, et al. F-18 FDG uptake in the large arteries: a new observation. Clin Nucl Med. 2001;26(4):314–319
  12. Ben-Haim S, Kupzov E, Tamir A, Israel O. Evaluation of 18F-FDG uptake and arterial wall calcifications using 18F-FDG PET/CT. J Nucl Med. 2004;45(11):1816–1821
  13. Yun M, Jang S, Cucchiara A, Newberg AB, Alavi A. 18F FDG uptake in the large arteries: a correlation study with the atherogenic risk factors. Semin Nucl Med. 2002;32(1):70–76
  14. Rudd JH, Warburton EA, Fryer TD, et al. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation. 2002;105(23):2708–2711
  15. Davies JR, Rudd JH, Fryer TD, et al. Identification of culprit lesions after transient ischemic attack by combined 18F fluorodeoxyglucose positron-emission tomography and high-resolution magnetic resonance imaging. Stroke. 2005;36(12):2642–2647
  16. Daugherty A. Mouse models of atherosclerosis. Am J Med Sci. 2002;323(1):3–10
  17. Reddick RL, Zhang SH, Maeda N. Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression. Arterioscler Thromb. 1994;14(1):141–147
  18. Ivan E, Khatri JJ, Johnson C, et al. Expansive arterial remodeling is associated with increased neointimal macrophage foam cell content: the murine model of macrophage-rich carotid artery lesions. Circulation. 2002;105(22):2686–2691
  19. Bender D, Munk OL, Feng HQ, Keiding S. Metabolites of (18)F-FDG and 3-O-(11)C-methylglucose in pig liver. J Nucl Med. 2001;42(11):1673–1678
  20. Bacharach SL, Bax JJ, Case J, et al. PET myocardial glucose metabolism and perfusion imaging. Part 1. Guidelines for data acquisition and patient preparation. J Nucl Cardiol. 2003;10(5):543–556
  21. Fukuyama H, Hayashi T, Katsumi Y, Tsukada H, Shibasaki H. Issues in measuring glucose metabolism of rat brain using PET: the effect of harderian glands on the frontal lobe. Neurosci Lett. 1998;255(2):99–102
  22. Tai YC, Ruangma A, Rowland D, et al. Performance evaluation of the microPET focus: a third-generation microPET scanner dedicated to animal imaging. J Nucl Med. 2005;46(3):455–463
  23. Cohade C, Mourtzikos KA, Wahl RL. “USA-Fat”: prevalence is related to ambient outdoor temperature-evaluation with 18F-FDG PET/CT. J Nucl Med. 2003;44(8):1267–1270
  24. Cohade C, Osman M, Pannu HK, Wahl RL. Uptake in supraclavicular area fat (“USA-Fat”): description on 18F-FDG PET/CT. J Nucl Med. 2003;44(2):170–176
  25. Bjornheden T, Levin M, Evaldsson M, Wiklund O. Evidence of hypoxic areas within the arterial wall in vivo. Arterioscler Thromb Vasc Biol. 1999;19(4):870–876
  26. Stary HC, Chandler AB, Dinsmore RE, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 1995;92(5):1355–1374
  27. Laitinen I, Marjamaki P, Haaparanta M, et al. The uptake of [F-18]-FDG and [H-3]-PK11195 on atherosclerotic plaques in mice. Annual congress of the European association of nuclear medicine; 2005 [Ref Type: Abstract].
  28. Dunphy MP, Freiman A, Larson SM, Strauss HW. Association of vascular 18F-FDG uptake with vascular calcification. J Nucl Med. 2005;46(8):1278–1284
  29. Mawlawi O, Podoloff DA, Kohlmyer S, et al. Performance characteristics of a newly developed PET/CT scanner using NEMA standards in 2D and 3D modes. J Nucl Med. 2004;45(10):1734–1742
  30. Narula J, Strauss HW. Imaging of unstable atherosclerotic lesions. Eur J Nucl Med Mol Imaging. 2005;32(1):1–5

PII: S0021-9150(06)00415-1

doi: 10.1016/j.atherosclerosis.2006.07.019

Atherosclerosis
Volume 192, Issue 2 , Pages 275-282 , June 2007

Article Tools

* Image Usage & Resolution